Thomas R. Staab II, Senior Vice President and CFO at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 25,200 shares at $8.09 ($204K) on 2018-11-08, disclosed to the SEC on 2018-11-09.
Open-market sale of $204k BCRX by Senior Vice President and CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.00 | 672 | $5K | 2.6% |
| 2 | $8.09 | 11,113 | $90K | 44.0% |
| 3 | $8.09 | 11,113 | $90K | 44.0% |
| 4 | $8.30 | 2,302 | $19K | 9.4% |
| Total | $8.11 avg | 25,200 | $204K | 100% |
| Filing → |
| BCRX | SELL | 2019-05-16 | $92K | — | Filing → |
| BCRX | SELL | 2019-05-13 | $224K | — | Filing → |
| BCRX | SELL | 2019-05-06 | $126K | — | Filing → |